- Home
- FUND vs ATAI Comparison
FUND vs ATAI Comparison
Compare FUND & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUND
- ATAI
- Stock Information
- Founded
- FUND 1988
- ATAI 2018
- Country
- FUND Canada
- ATAI Germany
- Employees
- FUND N/A
- ATAI N/A
- Industry
- FUND Investment Managers
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- FUND Finance
- ATAI Health Care
- Exchange
- FUND Nasdaq
- ATAI Nasdaq
- Market Cap
- FUND 236.5M
- ATAI 214.8M
- IPO Year
- FUND N/A
- ATAI 2021
- Fundamental
- Price
- FUND $8.03
- ATAI $1.61
- Analyst Decision
- FUND
- ATAI Strong Buy
- Analyst Count
- FUND 0
- ATAI 4
- Target Price
- FUND N/A
- ATAI $9.00
- AVG Volume (30 Days)
- FUND 32.5K
- ATAI 2.3M
- Earning Date
- FUND 01-01-0001
- ATAI 11-13-2024
- Dividend Yield
- FUND 6.64%
- ATAI N/A
- EPS Growth
- FUND N/A
- ATAI N/A
- EPS
- FUND 0.93
- ATAI N/A
- Revenue
- FUND N/A
- ATAI $331,000.00
- Revenue This Year
- FUND N/A
- ATAI $44.72
- Revenue Next Year
- FUND N/A
- ATAI N/A
- P/E Ratio
- FUND $8.33
- ATAI N/A
- Revenue Growth
- FUND N/A
- ATAI N/A
- 52 Week Low
- FUND $6.75
- ATAI $1.03
- 52 Week High
- FUND $8.47
- ATAI $2.85
- Technical
- Relative Strength Index (RSI)
- FUND 61.60
- ATAI 61.07
- Support Level
- FUND $7.77
- ATAI $1.53
- Resistance Level
- FUND $7.89
- ATAI $1.95
- Average True Range (ATR)
- FUND 0.09
- ATAI 0.22
- MACD
- FUND 0.00
- ATAI 0.03
- Stochastic Oscillator
- FUND 78.05
- ATAI 62.22
About FUND Sprott Focus Trust Inc.
Sprott Focus Trust Inc is a diversified closed-end investment company. Its primary investment objective is long-term capital growth. To achieve its objective, The Fund may invest its assets in equity securities and in direct obligations of the U.S. Government or its agencies and in the non-convertible preferred stocks & debt securities of domestic and foreign companies. It invests in various sectors, of which Materials, Financials, Energy, Information technology sector account for the majority weightage.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.